Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Bullboard Posts
Post by zoomzoom3on Jul 22, 2014 9:45pm
254 Views
Post# 22772070

Just for fun - Rough Estimates

Just for fun - Rough Estimates
ICO Rough Calculations Cash on hand - 8 Cents per share. Shares of Immune Pharma - 4 cents per share. Right there alone we are valued at 12 Cents per share and we are currently trading at 6-7 Cents??? We have iCo-007 which the market is valuing at 0 cents per share but IF they were to find a sub-group that responded to the treatment or found something else out about the study then we would need to assign a value to 007 again(Which I believe is very possible). Then we have iCo-008 which could bring in millions in milestone royalties from Immune Pharma and our own trials as well. And to top it off we have iCo-009. iCo-008 and iCo-009 have value but what exactly the value is tough to say but I would think that it could be worth another 10-20 cents per share. This just for fun would value ICO somewhere between 22- 32 Cents per share TODAY. So when whomever is done selling I would like to think that we will head higher towards a better valuation.
Bullboard Posts